About: Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.37 (-5.90%)
LABT NASDAQ Lakewood-Amedex Biotherapeutics Inc. Common Stock
Lakewood-Amedex Biotherapeutics Inc. Common Stock share price
Atividade de preço de LABT
Último preço
$ 0,380
Variação (24h)
-0,04 USD (9,16%)
Volume
924.09K
Volume (média 4 sem.)
-
Abertura
$ 0,41
Variação do dia
$ 0,37 - $ 0,42
Fechamento anterior
$ 0,42
Último negócio
11 Nov, 3:57 pm GMT+0
Atrasado
11 Nov, 3:57 pm GMT+0
LABT price performance
Atrasado
11 Nov, 3:57 pm GMT+0
LABT details
quote.marketSignals